RECRUITING

Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The primary objective of this trial is to measure changes in physiologic signals to quantify the status of the autonomic nervous system during opioid withdrawal and cravings.

Official Title

Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder

Quick Facts

Study Start:2024-11-21
Study Completion:2025-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06487533

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 50 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Caroline Benner
CONTACT
(210) 624-8046
caroline.benner@sparkbiomedical.com
Brooke Le
CONTACT

Principal Investigator

Navid Khodaparast, PhD
STUDY_CHAIR
Chief Science Officer
Melanie McWade, PhD
STUDY_DIRECTOR
Senior Director of Clinical Operations
Carlos Tirado, MD
STUDY_CHAIR
Medical Monitor

Study Locations (Sites)

Hazelden Betty Ford Foundation
Center City, Minnesota, 55012
United States
Battelle Memorial Institute
Columbus, Ohio, 43201
United States

Collaborators and Investigators

Sponsor: Spark Biomedical, Inc.

  • Navid Khodaparast, PhD, STUDY_CHAIR, Chief Science Officer
  • Melanie McWade, PhD, STUDY_DIRECTOR, Senior Director of Clinical Operations
  • Carlos Tirado, MD, STUDY_CHAIR, Medical Monitor

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11-21
Study Completion Date2025-07

Study Record Updates

Study Start Date2024-11-21
Study Completion Date2025-07

Terms related to this study

Keywords Provided by Researchers

  • Physiological Signals
  • Opioid
  • Detoxification
  • Cravings
  • Autonomic Nervous System

Additional Relevant MeSH Terms

  • Opioid Withdrawal
  • Opioid Use Disorder